Hypha are excited to present a poster describing the application of PolyCYPs enzyme kits to create oxidised derivatives of drug candidates. In this project conducted joint with AstraZeneca, we show that PolyCYPs enzymes were able to synthesize all monohydroxylated derivatives of a drug lead candidate.
Q2 2026 – PROTAC MetID focus
Q2 2026 newsletter – PROTAC MetID focus From tackling the metabolism of PROTACs to synthesising oxidised metabolites, our latest newsletter features a MetID study undertaken
Read More >
